Malarz Katarzyna, Mrozek-Wilczkiewicz Anna, Serda Maciej, Rejmund Marta, Polanski Jaroslaw, Musiol Robert
Institute of Chemistry, University of Silesia in Katowice, Katowice, Poland.
Silesian Center for Education and Interdisciplinary Research, University of Silesia in Katowice, Chorzów, Poland.
Oncotarget. 2018 Apr 3;9(25):17689-17710. doi: 10.18632/oncotarget.24844.
Thiosemicarbazones are chelators of transition metals such as iron or copper whose anticancer potency is intensively investigated. Although two compounds from this class have entered clinical trials, their precise mechanism of action is still unknown. Recent studies have suggested the mobilization of the iron ions from a cell, as well as the inhibition of ribonucleotide reductase, and the formation of reactive oxygen species. The complexity and vague nature of this mechanism not only impedes a more rational design of novel compounds, but also the further development of those that are highly active that are already in the preclinical phase. In the current work, a series of highly active thiosemicarbazones was studied for their antiproliferative activity Our experiments indicate that these complexes have ionophoric properties and redox activity. They appeared to be very effective generating reactive oxygen species and deregulating the antioxidative potential of a cell. Moreover, the genes that are responsible for antioxidant capacity were considerably deregulated, which led to the induction of apoptosis and cell cycle arrest. On the other hand, good intercalating properties of the studied compounds may explain their ability to cleave DNA strands and to also poison related enzymes through the formation of reactive oxygen species. These findings may help to explain the particularly high selectivity that they have over normal cells, which generally have a stronger redox equilibrium.
硫代氨基脲是铁或铜等过渡金属的螯合剂,其抗癌效力正在深入研究。尽管该类中的两种化合物已进入临床试验,但其确切作用机制仍不清楚。最近的研究表明,铁离子从细胞中被动员出来,同时核糖核苷酸还原酶受到抑制,并且会形成活性氧。这种机制的复杂性和模糊性不仅阻碍了新型化合物的更合理设计,也阻碍了那些已处于临床前阶段的高活性化合物的进一步开发。在当前的工作中,研究了一系列高活性硫代氨基脲的抗增殖活性。我们的实验表明,这些配合物具有离子载体性质和氧化还原活性。它们似乎能非常有效地产生活性氧并破坏细胞的抗氧化潜力。此外,负责抗氧化能力的基因被显著失调,这导致了细胞凋亡和细胞周期停滞。另一方面,所研究化合物良好的嵌入性质可能解释了它们切割DNA链以及通过产生活性氧毒害相关酶的能力。这些发现可能有助于解释它们对通常具有更强氧化还原平衡的正常细胞具有特别高选择性的原因。